| Primary |
| Hypertension |
27.8% |
| Hypersensitivity |
16.7% |
| Blood Cholesterol Increased |
11.1% |
| Bone Disorder |
11.1% |
| Coeliac Disease |
11.1% |
| Breast Cancer Female |
5.6% |
| Depression |
5.6% |
| Dyspepsia |
5.6% |
| Osteopenia |
5.6% |
|
| Rash |
40.0% |
| Hypersensitivity |
20.0% |
| Hypotension |
20.0% |
| Road Traffic Accident |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.4% |
| Rheumatoid Arthritis |
17.0% |
| Product Used For Unknown Indication |
14.9% |
| Osteoporosis |
8.5% |
| Pain |
6.4% |
| Ankle Swelling |
4.3% |
| Blood Pressure High |
4.3% |
| Calcium Deficiency |
4.3% |
| High Cholesterol |
4.3% |
| Bone Disorder |
2.1% |
| Diuretic Therapy |
2.1% |
| Headache |
2.1% |
| Hypertension |
2.1% |
| Mineral Supplementation |
2.1% |
| Plasma Cell Myeloma |
2.1% |
|
| Loss Of Consciousness |
16.7% |
| Blindness Transient |
8.3% |
| Drug Intolerance |
8.3% |
| Headache |
8.3% |
| Renal Failure |
8.3% |
| Self-medication |
8.3% |
| Syncope |
8.3% |
| Systemic Lupus Erythematosus |
8.3% |
| Tuberculin Test Positive |
8.3% |
| Urinary Tract Infection |
8.3% |
| Visual Acuity Reduced |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.2% |
| Rheumatoid Arthritis |
9.3% |
| Osteoporosis |
5.9% |
| Drug Use For Unknown Indication |
5.1% |
| Pain |
5.0% |
| Hypertension |
4.0% |
| Vitamin Supplementation |
3.9% |
| Depression |
2.6% |
| Anxiety |
2.5% |
| Atrial Fibrillation |
2.3% |
| Crohn's Disease |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Supplementation Therapy |
2.0% |
| Hypothyroidism |
1.9% |
| Osteopenia |
1.8% |
| Osteoporosis Postmenopausal |
1.7% |
| Osteoporosis Prophylaxis |
1.6% |
| Asthma |
1.5% |
| Hypersensitivity |
1.4% |
| Insomnia |
1.4% |
|
| Urinary Tract Infection |
11.1% |
| Vomiting |
11.1% |
| Pain In Extremity |
7.8% |
| Weight Decreased |
6.7% |
| Ataxia |
5.6% |
| Pulmonary Embolism |
5.6% |
| Fatigue |
4.4% |
| Headache |
4.4% |
| Oedema Peripheral |
4.4% |
| Pain |
4.4% |
| Weight Increased |
4.4% |
| Diarrhoea |
3.3% |
| Injection Site Pain |
3.3% |
| Laceration |
3.3% |
| Palpitations |
3.3% |
| Pruritus |
3.3% |
| Skin Disorder |
3.3% |
| Tachycardia |
3.3% |
| Viral Infection |
3.3% |
| Vitamin D Deficiency |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
92.3% |
| Constipation |
7.7% |
|
|
